
CAS 1199236-64-0
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide
CAS :Formule :C19H27ClFN3O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :383.8880Z944
CAS :Z944 is a T-type calcium channel blocker.Formule :C19H27ClFN3O2Degré de pureté :99.8% - 99.80%Couleur et forme :SolidMasse moléculaire :383.89N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide
CAS :Produit contrôlé<p>Applications N-Piperidinyl acetamide derivatives as calcium channel blockers and their use in the treatment of obesity.<br>References Lopez-Rodriguez, et al.: Bioorg. Med. Chem. Lett., 11, 2807 (2001), Yang, et al.: J. Med. Chem., 51, 6471 (2008),<br></p>Formule :C19H27ClFN3O2Couleur et forme :Off White SolidMasse moléculaire :383.89N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide
CAS :<p>N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide is a novel antiarrhythmic drug that inhibits the activation of cardiac cells. It was shown to inhibit proliferation and migration of human leukemia cells in vitro and to inhibit tumor growth in vivo. N-(1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide has been shown to have cardioprotective effects in Sprague Dawley rats, reducing the incidence of ventricular tachycardia and fibrillation. The clinical studies conducted so far have not revealed any adverse effects on the heart or other organs.</p>Formule :C19H27ClFN3O2Degré de pureté :Min. 95%Couleur et forme :White SolidMasse moléculaire :383.89 g/mol




